Extending Healthy Human Lifespan Using Gene Therapy
The coming decades will see most ailments from chronic metabolic disorders, to monogenic disease, to aging, tackled at the molecular level. The distinction between cure and enhancement will disappear. To date, therapies that alter the genes responsible for disease have been showing success in clinical trials. My goal is to streamline the regulatory approval of gene therapies with early patient access and subsequent data. I founded BioViva in 2015 for the purpose of analyzing medical data from current cutting edge gene therapies done in clinics worldwide by consent. Our researchers analyse the data, and thereby create a positive feedback loop, which then serves to improve innovative therapies. The future looks brilliant.
About the Author
Elizabeth Parrish is the Founder and CEO of BioViva, a company committed to extending healthy lifespans using cell technologies. Liz is a humanitarian, entrepreneur, innovator, and a leading voice for genetic cures. As a strong proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences.
She is the founder of the BioTrove Podcasts which is committed to offering a meaningful way for people to learn about and fund research in regenerative medicine.
Learn more about Liz here: https://www.linkedin.com/pub/liz-parrish/29/706/738